©1996-2019. All Rights Reserved. Online Journal
of Bioinformatics. You may not store these pages in any form except for
your own personal use. All other usage or distribution is illegal under
international copyright treaties. Permission to use any of
these pages in any other way besides the before mentioned must be gained in
writing from the publisher. This article is exclusively copyrighted in
its entirety to OJB publications. This article may be copied once but may not be,
reproduced or re-transmitted without the express permission of the editors.
Linking: To link to this page or any pages linking to this page you must link
directly to this page only here rather than put up your own page.
OJBtm
Online Journal of Bioinformatics©
Established 1995
ISSN 1443-2250
Volume 19(3):234-239, 2018.
Subtractive
genomics for membrane drug targets for antibiotic resistant Chlamydia trachomatis A/HAR-13.
Vijayakumari SM1*,
Shivkumar M1, Biplab
B2, Keshava M2, Jhinuk C2
1Department of Bioinformatics,KSW University, Bijapur,
India. 2Department of Biotechnology, PES Institute of technology, Bangalore,India .
ABSTRACT
Vijayakumari SM, Shivkumar M, Biplab B, Keshava M, Jhinuk C., Subtractive
genomics for membrane drug targets for antibiotic resistant Chlamydia
trachomatis A/HAR-13, Onl J Bioinform.,
19(3):234-239,
2018. A subtractive genomics approach
was employed to identify metabolic pathways-related candidate drug and vaccine
targets in Chlamydia trachomatis virulent
strain A/HAR-13. A filter for drug proteome based on pre-set
conditions to generate a set of membrane associated human-non homologous drug targets was used. Survival
and segregation of Chlamydia trachomatis
unique metabolic pathway proteins and structure generation of the membrane
associated drug targets was validated. Five membrane associated drug targets participating
in peptidoglycan biosynthesis; cell cycle caulobacter
& lipopolysaccharide biosynthesis were identified and their 3D structures
generated & validated. These putative drug targets identified can be used as
a platform for screening against a battery of anti-microbial leads. Computational analysis of the result
indicates that out of 919 proteins of Chlamydia
trachomatis A/HAR-13; 314 were found to be essential after subjecting the
non-homologous sequence to blastp against the DEG
database. The essential gene of Chlamydia
trachomatisA/HAR-13 is listed and analyzed for
cellular localization and biochemical metabolic pathway analysis. The list of
proteins predicted to have unique pathway is given and drug targets having
unique pathogenic specific pathways localized in membrane were considered for
further analysis since membrane bound proteins are easier to target and as they
are surface proteins they are exposed to immune system as can be used an
epitopes for vaccine design. A list of putative drug targets with its predicted
function, localization, and pathway is given.
Keywords: subtractive genomics, drug targets, Chlamydia.
FULL-TEXT (SUBSCRIPTION OR
PURCHASE ARTICLE $25USD)